![]()
Background: Current approaches to cancer drug therapy development lack a systematic way to connect cellular genetic information with therapeutic responses. While single-cell genomic technologies like ATAC-seq and RNA-seq provide detailed cellular profiles, translating this information into actionable therapeutic strategies remains challenging. The complexity of cancer cell heterogeneity and the vast number of possible drug combinations create a combinatorial explosion that is difficult to navigate using traditional experimental approaches. Existing methods often fail to capture the dynamic relationships between cellular states and drug responses, limiting their predictive power for personalized therapy design.
Technical Overview: Northeastern researchers have developed a novel deep learning platform that creates a multi-dimensional phenotypic space to map relationships between cellular genotypes and phenotypes. The system employs advanced neural network architectures to integrate multi-omics data and predict cellular responses to various therapeutic interventions. The platform can model complex cell fate transitions and predict optimal drug combinations by analyzing cellular state trajectories in high-dimensional space. This approach enables systematic exploration of drug repurposing opportunities by identifying novel therapeutic applications for existing compounds based on their effects on cellular phenotypes.
Benefits:
- Maps complex relationships between genotype and phenotype
- Enables visualization of cellular state transitions
- Predicts optimal drug combinations for personalized therapy
- Identifies novel drug repurposing opportunities
- Reduces time and cost of drug discovery processes
Application:
- Cancer Drug Development: Designing Combination Therapies
- Pharmaceutical Research: Drug response prediction and optimization
- Personalized Medicine: Tailoring treatments to individual patient profiles
- Drug Repurposing: Identifying new therapeutic applications for existing drugs
Opportunity:
- License
- Research collaboration
